Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antitumor Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT07749703
What this trial is testing

A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Histologically or Cytologically Confirmed Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 346
Early research (Phase 1)Study completedNCT03329937
What this trial is testing

Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer

Who this might be right for
Neoplasms, Breast
Tesaro, Inc. 21
Early research (Phase 1)Looking for participantsNCT07004296
What this trial is testing

HDM2005 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 72
Early research (Phase 1)Not Yet RecruitingNCT07088588
What this trial is testing

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid CancerMetastatic Solid TumorOvarian Cancer+3 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd 105
Testing effectiveness (Phase 2)Active Not RecruitingNCT05627856
What this trial is testing

GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL

Who this might be right for
NK/T Cell LymphomaVascular Immunomother T Cell LymphomaNon-Hodgkin Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 4
Testing effectiveness (Phase 2)Active Not RecruitingNCT06206837
What this trial is testing

Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Who this might be right for
Breast Cancer
Pfizer 71
Early research (Phase 1)Looking for participantsNCT05948865
What this trial is testing

CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
CancerCancer, Lung
Conjupro Biotherapeutics, Inc. 132
Early research (Phase 1)Study completedNCT06130722
What this trial is testing

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
Suzhou Forlong Biotechnology Co., Ltd 18
Not applicableUnknownNCT02950207
What this trial is testing

Prospective Observational Study of Antitumor Activity Correlation Between Hormonal Therapy and Expression miRNA100

Who this might be right for
Breast Cancer
Fondazione del Piemonte per l'Oncologia 180
Early research (Phase 1)Ended earlyNCT03700294
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ADC Therapeutics S.A. 18
Early research (Phase 1)Ended earlyNCT04209465
What this trial is testing

BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.

Who this might be right for
Solid Tumor
Black Diamond Therapeutics, Inc. 91
Early research (Phase 1)Active Not RecruitingNCT05557045
What this trial is testing

JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

Who this might be right for
Advanced CancerMetastatic CancerSolid Tumor+4 more
Jazz Pharmaceuticals 98
Early research (Phase 1)Looking for participantsNCT06707610
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

Who this might be right for
Advanced CancerAdvanced Solid Tumor
Shanghai Allink Biotherapeutics Co., Ltd. 234
Early research (Phase 1)Study completedNCT04047290
What this trial is testing

AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors

Who this might be right for
Neoplasms Malignant
Akesobio Australia Pty Ltd 80
Testing effectiveness (Phase 2)Ended earlyNCT05436990
What this trial is testing

Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor

Who this might be right for
Acral MelanomaMucosal Melanoma
Yonsei University 14
Early research (Phase 1)Looking for participantsNCT06803680
What this trial is testing

BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
BeOne Medicines 90
Early research (Phase 1)Looking for participantsNCT04993690
What this trial is testing

LP-168 in Participants With Relapse or Refractory B-Cell Lymphoma

Who this might be right for
B-cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD. 200
Testing effectiveness (Phase 2)Study completedNCT03802084
What this trial is testing

Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor

Who this might be right for
Desmoid Tumor
Hyo Song Kim 24
Early research (Phase 1)Study completedNCT03905148
What this trial is testing

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Who this might be right for
Solid Tumor, Adult
BeiGene 91
Testing effectiveness (Phase 2)Looking for participantsNCT05801237
What this trial is testing

PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor

Who this might be right for
Locally Advanced/Metastatic Solid Tumors
Shanghai HyaMab Biotech Co.,Ltd. 120
Next Page